ІнтерХім Competitors

💊 Farmak is the leader in the pharmaceutical market of Ukraine *. The company's product portfolio includes more than 450 modern medicines. ⬇️ Virtual tour of Farmak: https://youtu.be/gw7w0pj58Ag The company annually reinvests up to 90% of profits in development. The amount of investments for the last 10 years has made more than 250 million dollars. The production facilities, laboratory and technical complex of the enterprise are internationally certified and meet the high requirements of European GMP standards. The company's products are presented in 60 countries in the EU, Central and South America, the CIS, the Middle East, Asia, and more. Farmak is among the TOP-50 best companies in Ukraine, recognized as the largest taxpayer among pharmaceutical manufacturers in Ukraine and the best employer. ** ____________________ * by sales of drugs in monetary terms, according to Proxima Research ** According to the ratings of the publication "Power of Money" (2021), "RATING. Business in official figures "(2021)," Forbes "(2022). 🌐 Get to know more at our website: http://farmak.ua/en

BIOPHARMA Company is one of the TOP-10 local pharmaceutical manufacturers in Ukraine with the leading positions in several niche segments of the market and strong export stand in CIS. The priority vectors of the BIOPHARMA Company are medicinal products produced of human donated blood plasma, recombinant drugs and probiotics including drugs based on spore-forming bacteria. In total enterprise lets out over 130 names of the preparations and the list constantly extends. The quality, safety and potency are the main characteristics of medical drugs produced by BIOPHARMA Company. Existing quality management system corresponds to the international and national standards ISO 9000, as well as production of drugs according to the current European standards of GMP. The unique features of the company are: 1. The Company is the biggest in Ukraine and CIS countries (except of Russia) manufacturer of high technological immunobiological preparations produced from human blood plasma. (Bioven Mono®, Bioven®, Albumin, BioClot A® etc.). 2. The company has in its product list the widest in Ukraine and CIS countries (except of Russia) line of unique organopharmaceutical preparations produced from natural biological raw materials (Subalin Forte, Tseruloplazmin, Biosporin Forte etc.). 3. The company is manufacturer of the widest in Ukraine line of recombinant biopreparations manufactured on basis of high gen-engineering technologies (Laferobion®, Betfer -1a®, Betfer -1b®, Filstim® etc.). According to the best traditions of the pharmaceutical science, BIOPHARMA Company is permanently developing and modernizing its production facilities by contributing to the improvement of quality of life and support of health of millions of people. The team of BIOPHARMA Company, which is headed today by a young, vigorous team of professionals, thanks to new strategy of development, confidently walks forward and is ready to the further expansion of mutually advantageous cooperation.

Astrapharm is a Ukrainian GMP-certified pharmaceutical manufacturer operating since 2001, with a production facility in Vyshneve (Kyiv region) and headquarters spanning commercial and regulatory operations across Ukraine. We manufacture across three strategic directions: Own portfolio — Over 80 registered SKUs spanning prescription (Rx), over-the-counter (OTC), and dietary supplement categories across 11 therapeutic areas including cardiovascular, CNS, respiratory, gastrointestinal, endocrinology, pain and joint care, immunology, and nutraceuticals. Contract Manufacturing (CDMO) — We partner with pharmaceutical companies, nutraceutical brands, and private label clients across Europe who need reliable GMP-certified production. Our annual capacity exceeds 1 billion tablets, 100 million capsules, and 5 million sachets. Licensing and distribution partnerships — We out-license our established SKUs to distributors in Central Europe, CIS, and emerging markets, and partner with international brands to bring innovative formulations into Ukraine. What makes us a reliable manufacturing partner: over 25 years of operations, robust HACCP and regulatory frameworks, an in-house formulation and R&D team capable of supporting custom product development, and continuous production maintained through the challenges of recent years. We work with 100+ contract clients and established distribution partners including leading Ukrainian pharmacy chains and international ingredient suppliers. Connect with our business development team to discuss contract manufacturing, private label, or licensing opportunities.